CAB39L Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-87106
Key Product Details
Species Reactivity
Validated:
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Summary for CAB39L Antibody
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of human CAB39L. Peptide sequence: KVFVASPHKTQPIVEILLKNQPKLIEFLSSFQKERTDDEQFADEKNYLIK The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for CAB39L Antibody
![Western Blot: CAB39L Antibody [NBP2-87106]](https://resources.bio-techne.com/images/products/CAB39L-Antibody-Western-Blot-NBP2-87106-img0001.jpg "Western Blot: CAB39L Antibody [NBP2-87106]")
Western Blot: CAB39L Antibody [NBP2-87106]
Western Blot: CAB39L Antibody [NBP2-87106] - Host: Rabbit. Target Name: CAB39L. Sample Type: Hela Whole cell lysates. Antibody Dilution: 1.0ug/mlApplications for CAB39L Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CAB39L
Alternate Names
Antigen MLAA-34, bA103J18.3, calcium binding protein 39-like, calcium-binding protein 39-like, FLJ12577, MO25-BETA, Mo25-like protein, MO2L, RP11-103J18.3, sarcoma antigen NY-SAR-79, U937-associated antigen
Gene Symbol
CAB39L
Additional CAB39L Products
Product Specific Notices for CAB39L Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...